About
Drugs for autoimmune/metabolic and neurological diseases, focus on individuals with down syndrome
Areas of Focus
Categories
Small Molecule PharmaceuticalNorway
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
70
By Phase
PHASE3: 2
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06884280Collaborator
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
PHASE3Not yet recruiting
30 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
NCT05304442Collaborator
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
PHASE3Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2025
Locations (1)
Headquarters
Oslo, Norway
Map
Loading map...